BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, April 11, 2026
Home » Topics » Medical technology

Medical technology
Medical technology RSS Feed RSS

Appointments and advancements for Oct. 3, 2023

Oct. 3, 2023
New hires and promotions in the med-tech industry, including: Aperio, Augmedics, Baxter, Biocentriq, Delphinus, Olympus, Twist Bioscience.
Read More

Other news to note for Oct. 3, 2023

Oct. 3, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3B Scientific, Airlife, Amber Implants, Avanos Medical, Cervos Medical, Hengenix Biotech, Henlius USA, Neuronetics, Oncohost, Outset Medical, Oxford Biodynamics, Mdxhealth, Nanox, Phenomex, Ranfac, Trace Medical, SRL, Vela Diagnostics, Wallcur.
Read More

Regulatory actions for Oct. 3, 2023

Oct. 3, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Equashield, Neurosigma, Procisedx.
Read More

In the clinic for Oct. 2, 2023

Oct. 2, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Castle Biosciences, Dexcom, DNA Diagnostics Center.
Read More
Selution SLR

Cordis completes $1B+ Medalliance buy heavily weighted toward future milestones

Oct. 2, 2023
By Annette Boyle

Cordis Corp. covered its bets a bit as it closed the acquisition of M.A. Med Alliance SA (Medalliance) announced almost a year ago. While the total payment for the company could total $1.135 billion, it could take six years for the owners of privately held Medalliance to see most of the funds.


Read More

FDA’s draft rule on lab-developed tests not necessarily the last word

Oct. 2, 2023
By Mark McCarty
The U.S. FDA has finally let fly with a draft rule for regulation of lab-developed tests (LDTs), an 83-page document that delves into the legal controversies regarding whether the agency has the requisite statutory authority. However, Allyson Mullen, a director in the D.C. office of Hyman, Phelps & McNamara P.C., told BioWorld that the emergence of this draft rule doesn’t mean Congress won’t eventually be dragged back into the LDT fray, particularly if stakeholders litigate to overturn the draft.
Read More
Cyclopharm Technegas

FDA approves Cyclopharm’s Technegas combo product for visualizing pulmonary ventilation

Oct. 2, 2023
By Tamra Sami

After a long and bumpy path to approval, the U.S. FDA has finally given the green light to Cyclopharm Ltd’s Technegas combination product a day after the Sept. 29 PDUFA date.


Read More

Gendius CKD technology to be ‘transformative’ for patients and health care systems

Oct. 2, 2023
By Shani Alexander
Following the receipt of a U.K. Conformity Assessed (UKCA) mark for its kidney function diagnostic software, the CKD Screening Prioritizer (CSP), Gendius Ltd. is hoping to soon receive CE mark and then U.S. FDA approval next year. Given that people with type 2 diabetes are at a higher risk of developing chronic kidney disease, Gendius’ pre-screening software will be “transformative” for patients and health care systems, CEO Rory Cameron told BioWorld in an interview.
Read More
electroporation system
Patents

Researchers develop electroporation system to induce lysis of circulating tumor cells during hemodialysis

Oct. 2, 2023
By Simon Kerton
U.S. researchers reported seeking patent protection for methods to neutralize circulating tumor cells (CTCs) during hemodialysis to prevent cancer metastasis and reduce cancer-related deaths.
Read More

Appointments and advancements for Oct. 2, 2023

Oct. 2, 2023
New hires and promotions in the med-tech industry, including: Bonalive Biomaterials, Ceribell, Cutera, Shoulder Innovations, Spectral Medical, Tactile Systems.
Read More
Previous 1 2 … 565 566 567 568 569 570 571 572 573 … 10241 10242 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 10, 2026.
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 7, 2026
  • Connecting puzzle pieces

    Korsana boosts Alzheimer’s work with reverse merger, $380M financing

    BioWorld Science
    Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld
    Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing